Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells-Reference-Cited by-同舟云学术

Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells

Published:2018-10 Issue:4 Volume:11 Page:929-943
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Tusa Ignazia,Cheloni Giulia,Poteti Martina,Gozzini Antonella,DeSouza Ngoc Ho,Shan Yi,Deng Xianming,Gray Nathanael S.,Li Shaoguang,Rovida Elisabetta,Dello Sbarba Persio

Funder

Associazione Italiana per la Ricerca sul Cancro

Istituto Toscano Tumori

Università degli Studi di Firenze

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference66 articles.

1. Characterization of a human basophil-like cell line (LAMA-84);Blom;Scand. J. Immunol.,1996

2. Abl-kinase-sensitive levels of ERK5 and its intrinsic basal activity contribute to leukaemia cell survival;Buschbeck;EMBO Rep.,2005

3. Multifunctional role of Erk5 in multiple myeloma;Carvajal-Vergara;Blood,2005

4. All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinib;Cassuto;Oncotarget,2012

5. Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine;Cheloni;Blood,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-10

2. Role of Erk5 expressed in bone marrow mesenchymal stem cells on bone homeostasis and its potential applications in cancer treatment;Oncoscience;2024-05-20

3. Bone and Extracellular Signal-Related Kinase 5 (ERK5);Biomolecules;2024-05-04

4. MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells;Cancer Research Communications;2023-01-30

5. Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells;BMC Cancer;2022-12-02